Sergio Traversa, Chief Executive Officer at RELMADA THERAPEUTICS, INC. (RLMD), sold 58,695 shares at $19.01 ($1.1M) on 2022-06-30, disclosed to the SEC on 2022-07-05.
Open-market sale of $1.1M RLMD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.01 | 10,698 | $203K | 18.4% |
| 2 | $19.01 | 10,698 | $203K | 18.4% |
| 3 | $19.37 | 5,314 | $103K | 9.3% |
| 4 | $19.37 | 5,314 | $103K | 9.3% |
| 5 | $18.32 | 4,068 | $75K | 6.8% |
| 6 | $18.32 | 4,068 |
| $75K |
| 6.8% |
| 7 | $18.45 | 8,848 | $163K | 14.8% |
| 8 | $18.45 | 8,848 | $163K | 14.8% |
| 9 | $18.48 | 839 | $16K | 1.4% |
| Total | $18.80 avg | 58,695 | $1.1M | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |